北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
Individualized Intervention Guided by BCR-ABL Transcript Levels after HLA-Identical Sibling Donor Transplantation Improves HSCT Outcomes for Patients with Chronic Myeloid Leukemia
作者: Huang, Xiao-Jun; Xu, Lan-Ping; Liu, Kai-Yan; Liu, Dai-Hong; Chen, Huan; Liu, Yan-Rong; Chen, Yu-Hong; Han, Wei; Wang, Yu
关键词: HLA-matched ; Blood and marrow transplantation ; Chronic myeloid leukemia ; BCR-ABL
刊名: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
发表日期: 2011-05-01
DOI: 10.1016/j.bbmt.2010.07.023
卷: 17, 期:5, 页:649-656
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Hematology ; Immunology ; Transplantation
研究领域[WOS]: Hematology ; Immunology ; Transplantation
关键词[WOS]: STEM-CELL TRANSPLANTATION ; REDUCED-INTENSITY TRANSPLANTATION ; COMPLETE CYTOGENETIC RESPONSE ; CHRONIC MYELOGENOUS LEUKEMIA ; TERM-FOLLOW-UP ; LYMPHOCYTE INFUSION ; IMATINIB MESYLATE ; WORKING PARTY ; RELAPSE ; CML
英文摘要:

The aim of this study was to determine the effect of individualized intervention guided by BCR-ABL transcript levels after hematopoietic stem cell transplantation (HSCT) on relapse and leukemia-free survival (LFS) of patients with chronic myelogenous leukemia (CML). Eighty-four consecutive patients who received HLA-identical sibling HSCT were enrolled. The patients were conditioned with a modified busulfan and cyclophosphamide regimen, and received stem cells from a HLA-identical sibling donor. Patients were identified as high risk of relapse based on serial monitoring of post-HSCT BCR-ABL transcript levels, and patients in the high-risk group were given individualized intervention. Interventions included immunosuppressant withdrawal, modified donor lymphocyte infusion, and imatinib mesylate. Engraftment was successful in all patients. Twenty-eight patients were categorized as high risk because of higher post-HSCT BCR-ABL transcript levels and received intervention. The 56 low-risk patients received no intervention. Twenty-five high-risk patients achieved complete molecular remission at a median of 49 days (range: 18-232 days) after intervention. Two high-risk patients and 1 low-risk patient ultimately relapsed, the 4-year relapse rate was 3.9% +/- 4.4%. Overall 4-year survival was 89.0% +/- 7% and the 4-year LFS was 89.2% +/- 6.8%. All surviving patients remains in complete molecular remission after a median of 1481(1040-1794) days follow-up. Individualized intervention based on the post-HSCT BCR-ABL transcript level can decrease relapse and increase LFS of patients with CML after HLA-identical sibling HSCT. Biol Blood Marrow Transplant 17: 649-656 (2011) (C) 2011 American Society fir Blood and Marrow Transplantation

语种: 英语
所属项目编号: 30725038 ; IRT0702 ; 2006AA02Z4A0
项目资助者: National Outstanding Yong Scientists&prime ; Foundation of China ; Program for Innovative Research Team in University ; HI-Tech Research Development Program of China 863
WOS记录号: WOS:000290061500007
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/62980
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China

Recommended Citation:
Huang, Xiao-Jun,Xu, Lan-Ping,Liu, Kai-Yan,et al. Individualized Intervention Guided by BCR-ABL Transcript Levels after HLA-Identical Sibling Donor Transplantation Improves HSCT Outcomes for Patients with Chronic Myeloid Leukemia[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,2011,17(5):649-656.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Huang, Xiao-Jun]'s Articles
[Xu, Lan-Ping]'s Articles
[Liu, Kai-Yan]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Huang, Xiao-Jun]‘s Articles
[Xu, Lan-Ping]‘s Articles
[Liu, Kai-Yan]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace